Design and redesign journey of a drug for transthyretin amyloidosis

被引：0
|
作者：
Francisca Pinheiro
Salvador Ventura
机构：
[1] Universitat Autònoma de Barcelona
[2] Institut de Biotecnologia i Biomedicina
[3] Departament de Bioquímica i Biologia Molecular
来源：
Neural Regeneration Research | 2025年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R91 [药物基础科学];
学科分类号：
1007 ;
摘要：
The misfolding and subsequent aggregation of proteins into amyloid fibrils underlie the onset of a variety of human disorders collectively known as amyloidosis.Transthyretin (TTR) is one of the> 30 amyloidogenic proteins identified to date and is associated with a group of highly debilitating and life-threatening disorders called TTR amyloidosis (ATTR).ATTR comprises senile systemic amyloidosis,
引用
收藏
页码：1096 / 1097
页数：2
相关论文
共 50 条
  • [21] TAFAMIDIS FOR TRANSTHYRETIN AMYLOIDOSIS
    de Lartigue, J.
    DRUGS OF TODAY, 2012, 48 (05) : 331 - 337
  • [22] Transthyretin Amyloidosis (ATTR)
    Benson, Merrill D.
    BRAIN PATHOLOGY, 2019, 29 : 61 - 62
  • [23] Transthyretin cardiac amyloidosis
    Eicher, J. C.
    Audia, S.
    Damy, T.
    REVUE DE MEDECINE INTERNE, 2020, 41 (10): : 673 - 683
  • [24] Transthyretin Amyloidosis and the Kidney
    Lobato, Luisa
    Rocha, Ana
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (08): : 1337 - 1346
  • [25] Management of transthyretin amyloidosis
    Condoluci, Adalgisa
    Theaudin, Marie
    Schwotzer, Rahel
    Pazhenkotti, Aju P.
    Arosio, Paolo
    Averaimo, Manuela
    Bacher, Ulrike
    Bode, Peter
    Cavalli, Andrea
    Dirnhofer, Stefan
    Djerbi, Nadia
    Dobner, Stephan
    Fehr, Thomas
    Garofalo, Maura
    Gaspert, Ariana
    Gerull, Sabine
    Heimgartner, Raphael
    Hubers, Annemarie
    Jung, Hans H.
    Kessler, Chiara
    Knopfel, Raphael
    Laptseva, Natallia
    Magini, Giulia
    Manka, Robert
    Mazzucchelli, Luca
    Meyer, Martin
    Mihaylova, Violeta
    Monney, Pierre
    Mylonas, Alessio
    Nkoulou, Rene
    Pabst, Thomas
    Pfister, Otmar
    Rufer, Axel
    Schmidt, Adrian
    Seeger, Harald
    Stampfli, Simon F.
    Stirnimann, Guido
    Suter, Thomas
    Treglia, Giorgio
    Tzankov, Alexandar
    Vetter, Friederike
    Zweier, Markus
    Flammer, Andreas J.
    Gerber, Bernhard
    SWISS MEDICAL WEEKLY, 2021, 151
  • [26] The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology
    Plante-Bordeneuve, Violaine
    Suhr, Ole B.
    Maurer, Mathew S.
    White, Barbara
    Grogan, Donna R.
    Coelho, Teresa
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (01) : 77 - 84
  • [27] Transthyretin Induced Amyloidosis Interactions, Mechanisms and Potent Drugs Design
    Jakubowski, Rafal
    Skrzyniarz, Piotr
    Peplowski, Lukasz
    Nowak, Wieslaw
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 661A - 661A
  • [28] Transthyretin mutations in amyloidosis
    Booth, DR
    Gillmore, JD
    Pepys, MB
    Hawkins, PN
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 554 - 555
  • [29] Transthyretin cardiac amyloidosis
    Porcari, Aldostefano
    Fontana, Marianna
    Gillmore, Julian D.
    CARDIOVASCULAR RESEARCH, 2023, 118 (18) : 3517 - 3535
  • [30] Cardiac transthyretin amyloidosis
    Dungu, Jason N.
    Anderson, Lisa J.
    Whelan, Carol J.
    Hawkins, Philip N.
    HEART, 2012, 98 (21) : 1546 - 1554
12345